Immuron (IMRN) Net Margin (2016 - 2024)
Immuron's (IMRN) quarterly Net Margin came in at 88.01% in Q4 2023, down 2762.0% year-on-year from 3.31% in Q4 2022, and up 94.11% quarter-over-quarter from 1493.47% in Q2 2023.
Immuron (IMRN) Net Margin (2016 - 2024) Analysis & Trends
Immuron's Net Margin history runs 8 years deep, the most recent figure standing at 88.01% for Q4 2023.
- On a quarterly basis, Net Margin fell 2762.0% year-over-year to 88.01% in Q4 2023; TTM through Dec 2023 was 109.53%, a 9722.0% decrease from a year earlier, with the FY2025 full-year figure at 71.58%, down 7163.0% from the prior year.
- Net Margin improved to 88.01% in Q4 2023 per IMRN's latest filing, from 1493.47% in the prior quarter.
- Across five years, Net Margin topped out at 0.64% in Q4 2019 and bottomed at 386591061.41% in Q4 2020.
- The 5-year median for Net Margin is 436.16% (2021), against an average of 64432248.04%.
- Across the five-year window, Net Margin plunged 2000000000 bps in 2020 and surged 2000000000 bps in 2021, its largest moves.
- Year by year, Net Margin stood at 0.64% in 2019, then sank by 2000000000 bps to 386591061.41% in 2020, then soared by 100 bps to 784.3% in 2021, then soared by 92 bps to 60.39% in 2022, then sank by 46 bps to 88.01% in 2023.
- Per Business Quant, the three latest IMRN Net Margin figures stand at 88.01% (Q4 2023), 1493.47% (Q2 2023), and 60.39% (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -20.45% |
| Dec 31, 2023 | -88.01% |
| Jun 30, 2023 | -1,493.47% |
| Dec 31, 2022 | -64.91% |
| Dec 31, 2021 | -784.30% |
| Dec 31, 2020 | -400,117,498.15% |
| Dec 31, 2019 | -0.64% |
| Dec 31, 2018 | -161.71% |
| Dec 31, 2017 | -205.84% |
| Dec 31, 2016 | -490.79% |
| Jun 30, 2016 | -379.89% |